Haptoglobin gene polymorphism and iron profile in sickle cell disease patients with inflammation in Yaounde, Cameroon

• Published in: Molecular genetics & genomic medicine Vol. 12; no. 1; pp. e2302 - n/a
• Main Authors: Tuono, Romaric De Manfouo, Simo, Josué Louokdom, Nya, Prosper Cabral Biapa, Chedjou, Jean Paul, Fotsing, Christian Bernard Kengne, Chetcha, Bernard Claude, Tah, Calvino Fomboh, Tayou, Claude Tagny, Mbatcham, Wilfried Fon, Pieme, Constant Anatole
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01-01-2024
• Subjects: Alleles; Anemia; Anemia, Sickle Cell - genetics; Biotechnology; Cameroon; Chi-square test; Cytokines; Disorders; Ferritin; Gene polymorphism; Genotyping; Haptoglobin; haptoglobin polymorphism; Haptoglobins - genetics; hematological profile; Hematology; Hemoglobin; Hemoglobinopathy; Hospitals; Humans; Inflammation; Inflammation - genetics; Iron; Iron - analysis; Iron - metabolism; Laboratories; major sickle cell syndrome; Mathematical analysis; Medical research; Parameters; Patients; Polymorphism; Polymorphism, Genetic; Proteins; Public health; serum iron; Sickle cell disease; Statistical analysis; Statistical methods; Statistics; Thrombocytosis; Cameroon; serum iron; hematological profile; haptoglobin polymorphism; major sickle cell syndrome; inflammation
• ISSN: 2324-9269; 2324-9269
• DOI: 10.1002/mgg3.2302

Background
Major sickle cell syndromes are the most common hemoglobinopathy in the world. The sickle cell patients are subjected to several factors causing inflammation, and the genetic identification of each individual allows to focus the possibility of allelic variations influence of a specific gene and then the polymorphism. This study aims at determining the distribution of HP gene (OMIM#140100) and their involvement on hematological parameters and the iron profile in the sickle cell patients presenting an inflammation condition during major sickle cell syndromes in Cameroun.
Methods
A case–control analytical study has been conducted over a period of 6 months. Cases consisting of sickle cell patients in a situation of inflammation and control of non‐inflamed sickle cell patients. The patients presenting major sickle cell syndromes, interned and/or followed at the Hematology Department of the Regional Hospital of Bafoussam and the Central Hospital of Yaoundé have been recruited. HP genotyping was carried out at the Laboratory for Public Health Research Biotechnologies (LAPHER‐Biotech) in Yaoundé using allele‐specific PCR. Also, inflammatory, hematological parameters and martial assessment were explored by standard methods. Statistical analysis of the data was performed using the statistical tool R version 4.1.1. The comparison of proportions of alleles was made with the chi‐square test, and the Wilcoxon test was used to compare the median between different groups using the statistical tool R version 4.1.1.
Results
We analyzed the samples of 149 patients. The HP polymorphism describes a significant frequency of the “1F” allele (69.8%) followed by the “2” allele (46.31%). In addition, 80 patients (53.69%), 48 (32.21%), and 21 (14.09%) presented the genotype HP 1‐1, HP 2‐1, and HP 2‐2, respectively. And eighty‐one percent (81%) patients with genotype HP 2‐2 showed a significant higher relative frequency of thrombocytosis compared with the genotype HP 1‐1 and HP 2‐1, respectively (51.2% and 68.8%, p = 0.087). The proportion of inflammation in the HP 2‐2 group was higher (57.1%) compared with the other groups (respectively 42.5% and 35.4% in the HP 1‐1 and HP 2‐1 groups). Furthermore, the median CRP was significantly higher in the HP 2‐2 group compared with the other groups (p = 0.039). Moreover, the entire population of the HP 2‐2 group showed an elevation of ferritin and IL6 unlike the HP 1‐1 and HP 2‐1 groups.
Conclusion
This study demonstrates a higher frequency of genotype HP 1‐1 followed by the HP 2‐2 genotype in patients with major sickle cell syndromes. However, a larger proportion of patients with genotype HP 2‐2 are associated with hematological profile disorders, inflammation, and dysregulation of iron metabolism. Then, the haptoglobin polymorphism contributes to the severity of major sickle cell syndromes.